Facebook
X
LinkedIn
ForwardSept 17, 2025 MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026: Discovery, First Demonstration and Dissemination of Ether at MGH, 1846 -Archive
Description
This activity provides on-demand archived lectures from the MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026 series. The MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026 sessions are designed to increase knowledge among clinicians in an interprofessional setting about controlled substance risk assessment and current evidence-based care models for chronic pain and accessing pain care across underserved populations. We hope to close professional practice gaps utilizing interdisciplinary collaboration, education and training, community engagement, policy and advocacy, and research and innovation.
Course Directors:
Ronald Kulich PhD & Thomas Cheng, MD, PhD & Roxanne Bavarian. DMD, DMSc & Michael E. Schatman, PhD & Matthew G. Fortino, PsyD & Elizabeth Hatfield, DDS & David Alexander Keith, DMD, BDS & Christopher Robinson, MD, PhD
Coordinator:
Ascher Kulich
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at [email protected].
You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.
Target Audience
This activity is intended for Physicians, dentists, psychologists, nurses, students, residents, fellows with specialties of Oral surgery, Orofacial Pain, Pain Medicine and Sleep Medicine.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify patients with substance use disorders based on current data on overdose. Participants will be able to state at least two ways the clinician can curb the over-prescription of opioids for pain.
- Use the Prescription Drug Monitoring Program (PDMP) and identify other available screeners for substance misuse.
- List at least one strategy involved and/or resource available to help manage patients with substance misuse, with particular reference to underserved practice groups.
- Recognize three components of interprofessional care that predict improved patient outcomes.
- Summarize one way learning from or with an interprofessional team benefits the patient when treating substance use disorders.
Additional Information
Mass General Brigham
Course Directors
Ronald Kulich PhD
Thomas Cheng, MD, PhD
Roxanne Bavarian. DMD, DMSc
Michael E. Schatman, PhD
Matthew G. Fortino, PsyD
Elizabeth Hatfield, DDS
David Alexander Keith, DMD, BDS
Christopher Robinson, MD, PhD
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. All reviewers have no relevant relationships with ineligible companies.
The following planners have reported no relevant financial relationship with an ineligible company:
Roxanne Bavarian. DMD, DMSc
Gary Brenner, MD, PhD
Jennifer Cheng, CNP
Thomas Cheng, MD, PhD
Kathryn Dolan, RDH
Matthew G. Fortino, PsyD
Elizabeth Hatfield, DDS
Mohammed A. Issa, MD
David Alexander Keith, DMD, BDS
Anna Kim, RN
Ronald Kulich PhD
Robert Nersasian , DMD
Christopher Robinson, MD, PhD
Michael E. Schatman, PhD
Michael A. Scialabba, DDS
Christine Sieberg, PhD
Donna Sultan, MBA
Yuanming Xu, DDS, MMSc
Yi Zhang, MD, PhD
The following planners have reported a relevant financial relationship with an ineligible company:
Robert Jason Yong, MD, MBA
Consultant: Medtronic, Boston Scientific, Nevro, Biotronik, Abbot
Carol Warfield, MD
Consultant: Abbvie, Johnson & Johnson (ended)
The following speakers have no relevant financial relationship with an ineligible company:
TBD
The following speakers have reported a relevant financial relationship with an ineligible company:
TBD
ACCREDITATION
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dentist
Mass General Brigham is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Mass General Brigham designates this activity for 1 continuing education credit.
Nursing
Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Psychology
1 Continuing Education (CE) credit are awarded
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Continuing Education Credit for Dentists
- 1.00 Nursing Contact Hours
- 1.00 Participation
- 1.00 Continuing Education (CE) for Psychologists